Nephros, Inc.

NEPH · NasdaqCM · Stock · Healthcare
$3.65
+3.99% today
Delayed price,

What Nephros does

Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Key facts

Sector
Healthcare
Industry
Medical Instruments & Supplies
Market cap
$39.6M
P/E (ttm)
24.3
Forward P/E
17.4
Dividend yield
0.00%
Beta
1.64
Profit margin
8.4%
Employees
36
Headquarters
South Orange, NJ, United States
Exchange
NasdaqCM

Performance

1 Month
-15.3%
3 Months
-3.4%
6 Months
+23.7%
1 Year
-25.4%
5 Years
-47.5%
$2.6652-week range$6.42
Biggest setback — last 12 months
-49.6%
27 Oct 2025 → 30 Mar 2026
Fell from $5.70 to $2.87 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+61.3%
30 Mar 2026 → 10 Aug 2026
Ran from $2.87 to $4.63 — its strongest sustained advance this year.

Price outlook — trend & volatility model

● Trend: Below long-term trend
Price sits below its 200-day average, but the shorter-term averages are not cleanly aligned above/below it.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$2.87 (-21.3%)$3.65$4.64 (+27.1%)
3 Months$2.41 (-34.0%)$3.65$5.53 (+51.4%)
6 Months$2.03 (-44.4%)$3.65$6.56 (+79.9%)
12 Months$1.59 (-56.4%)$3.65$8.37 (+129.4%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 83.0%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent headlines

Recent insider activity

Acquired 2,418 shares — Amron Arthur H, Director · 2026-08-14
Acquired 3,574 shares — Amron Arthur H, Director · 2026-06-12
Acquired 120,000 shares at $1.44 — Banks Robert R. Jr., President and CEO · 2026-03-25
Acquired 68,861 shares at $1.71 — Krandel Judy, Chief Financial Officer · 2026-03-25
Acquired 3,610 shares — Amron Arthur H, Director · 2026-03-18
Source: SEC Form 4 filings. An "acquired" entry with no price is typically a stock award or option exercise rather than an open-market purchase. Search all insider trades →

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.